Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IxaPD in Relapsed Multiple Myeloma
NCT04989140Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2021
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands, Molecular Glues
- Countries
- 1
01
Overview
A Phase 4 trial of ixazomib, pomalidomide, dexamethasone in multiple myeloma (MM), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
ixazomibpomalidomidedexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04989140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04989140.